Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine for Neurogenic Orthostatic Hypotension
NCT00004268Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Neurogenic Orthostatic Hypotension (nOH) comparing Midodrine with Placebo (2 arms). Primary endpoints: Safety and Efficacy. Started Apr 2001; status: completed.
02
Drugs
midodrine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00004268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004268.